- Vertex was sole bidder in high-premium Crinetics acquisitionAnalysts expect new details on the lead-up to the deal “are likely to reignite” investor scrutiny that Vertex overpaid in what’s poised to be its largest-ever transaction.BioPharma Dive · 6d ago↗ source
- GSK lung cancer drug gets speedy approval following $10.6B dealThe clearance is GSK’s first for a lung cancer medicine and the latest step forward in a yearslong push by the British drugmaker into oncology.BioPharma Dive · 6d ago↗ source
- FDA swiftly puts Makary era in the rearview mirrorAs the White House mulls a pick to lead the FDA, the Trump administration has been washing away the mark of former Commissioner Marty Makary, in a refresh that includes everything from reconsidered…Endpoints